OHI vs JAN Stock Comparison

Omega Healthcare Investors and Janus Living Prices as of Nov 13, 2026 Peers: Industry group
JAN Janus Living, Inc.
$31.82 +9.8% 1M
Market cap
$7.33B
P/E
–
Revenue (TTM)
$835.56M
Div. yield
–
Healthcare REITs Real Estate

Head to Head

5 decided of 12

Omega Healthcare Investors leads on 5 of the 12 questions below (Omega Healthcare Investors 5). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionOHIJANLeader
Larger companyMarket capitalisation $14.36B $7.33B OHI
Cheaper on earningsLower P/E, profitable companies only 18.8x -3,392x –
Cheaper on forward earningsLower price / next fiscal year consensus EPS 17.8x 318.2x OHI
Faster revenue growthRevenue growth, trailing twelve months +14.0% — –
More profitableNet margin, trailing twelve months 58.1% -0.3% OHI
Better return on capitalReturn on invested capital — -21.2% –
Less leveragedLower net debt / EBITDA — — –
Higher dividend yieldTrailing dividend yield 0.00% 0.00% –
Better 1-year returnPrice return, last 12 months +8.3% — –
Better 5-year returnAnnualised price return, 5 years +10.4%/yr — –
Less volatileAnnualised volatility, 1 year 21.4% 28.9% OHI
Higher overall scoreMean of the five percentile scores vs peers 74/100 25/100 OHI

Percentile Scorecard

OHIJAN

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisOHIJAN
Valuation 63 #56 of 149 1 #147 of 149
Growth 90 #16 of 147 –
Profitability 90 #15 of 144 26 #107 of 144
Financial Health 91 #14 of 149 72 #43 of 149
Shareholder Returns 36 #89 of 139 2 #136 of 139
Overall 74 25
  • OHI ranked among 150 companies in Property REITs
  • JAN ranked among 150 companies in Property REITs

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodOHIJANSPY
1 month +4.3%+9.8% -2.0%
3 months +1.1%+3.9% -2.8%
6 months -0.6%+19.3% +2.0%
Year to date +6.1%— +10.6%
1 year +8.3%— +12.2%
3 years +48.8%— +68.1%
3 years, per year +14.2%— +18.9%
5 years +63.7%— +61.4%
5 years, per year +10.4%— +10.1%
10 years +65.8%— +248.5%
10 years, per year +5.2%— +13.3%

Risk

MeasureOHIJANSPY
Volatility, 1Y 21.4%28.9% 13.6%
Downside volatility, 1Y 21.1%26.9% 13.9%
Beta vs S&P 500, 1Y -0.16-0.01 1.00
Return / volatility, 1Y 0.39— 0.90
Max drawdown, 5Y -23.3%-13.8% -25.4%
From 52-week high -9.1%-3.2% -3.2%
52-week high $51.74$32.88 $779.14
52-week low $42.93$22.88 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleOHIJAN
P/E now vs peer median 18.8xmedian 26.1x -3,327xmedian 26.1x
P/S now vs peer median 10.9xmedian 4.3x 8.9xmedian 4.3x
EV/EBITDA now vs peer median 9.8xmedian 14.5x -10.9xmedian 14.5x
P/FCF now vs peer median 26.4xmedian 21.4x -3.5xmedian 21.4x
P/B now vs peer median 2.5xmedian 1.2x 1.8xmedian 1.2x
PEG now vs peer median 0.50median 1.75 —median 1.75

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsOHIJAN
Revenue $1.31B $835.56M
Gross profit $762.04M –
Operating income $1.25B -$871.49M
Net income $797.03M $38.54M
Free cash flow $540.81M -$2.15B
EPS (diluted) $2.37 $-0.01
Cash & equivalents $195.90M $338.06M
Shares (diluted) 321.01M 225.97M
Enterprise value $14.07B $4.47B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricOHIJAN
P/E 18.8x -3,327x
P/FCF 26.4x -3.5x
P/Operating cash flow 16.7x 30.0x
P/S 10.9x 8.9x
P/B 2.5x 1.8x
P/Tangible book 2.5x 2.0x
EV/EBITDA 9.8x -10.9x
EV/EBIT 12.9x -8.2x
EV/Revenue 10.8x 8.5x
EV/FCF 26.1x -3.3x
EV/Operating cash flow 16.5x 28.7x
PEG (3Y EPS CAGR) 0.50 –

Growth

14 metrics
MetricOHIJAN
Revenue growth (1Y) 14.0% –
Revenue CAGR (3Y) 15.3% –
Gross profit growth (1Y) – –
Gross profit CAGR (3Y) – –
Operating income growth (1Y) 77.0% –
Operating income CAGR (3Y) – –
Net income growth (1Y) 43.9% –
Net income CAGR (3Y) 49.4% –
EPS growth (1Y) 35.8% –
EPS CAGR (3Y) 37.7% –
Operating cash flow growth (1Y) -2.5% –
Operating cash flow CAGR (3Y) 12.1% –
Free cash flow growth (1Y) 15.4% –
Free cash flow CAGR (3Y) 10.5% –

Profitability

14 metrics
MetricOHIJAN
Gross margin 58.1% –
EBITDA margin 109.4% -78.3%
Operating margin 95.7% -104.3%
Pretax margin 60.7% 4.7%
Net margin 58.1% -0.3%
FCF margin 41.3% -257.6%
Operating cash flow margin 65.2% 29.7%
Return on equity 14.0% 1.0%
Return on assets 7.9% 0.8%
Return on invested capital – -21.2%
Return on capital employed – –
Asset turnover 0.1x 0.2x
Cash conversion (OCF / net income) 1.1x 6.4x
Stock comp / revenue 5.2% 0.1%

Financial Health

11 metrics
MetricOHIJAN
Debt / assets – –
Debt / equity – –
Net debt / EBITDA – –
Debt / FCF – –
Liabilities / assets 43.1% 21.0%
Equity / assets 56.9% 79.0%
Interest coverage 5.6x -407.8x
Current ratio – –
Quick ratio – –
Cash ratio – –
Altman Z-score – –

Shareholder Returns

7 metrics
MetricOHIJAN
Dividend yield 5.7% 1.3%
Net buyback yield -2.8% -11.2%
Shareholder yield 2.9% -9.9%
Payout ratio (earnings) – –
Payout ratio (FCF) – –
Dividend growth (1Y) – –
Dividend CAGR (3Y) – –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusOHIJAN
Forward P/E 17.8xFY2026 318.2xFY2026
EPS, next fiscal year $2.64FY2026 $0.10FY2026
EPS growth, next FY +36.1%FY2026 +150.0%FY2026
EPS growth, the year after -19.3% -10.0%
Revenue, next fiscal year $1.17BFY2026 $885.94MFY2026
Revenue growth, next FY +18.5%FY2026 +27.8%FY2026
Revenue growth, the year after -1.0% +42.3%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersOHIJAN
Held by institutions 82.7% 38.1%
Institutions holding 764 162
Change in shares held, QoQ +6.2% +56.8%
Institutions buying 391 137
Institutions selling 245 19
Buyers to sellers 1.60 7.21

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

OHIJAN
OHI 1.00 0.53
JAN 0.53 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, OHI and JAN?

Omega Healthcare Investors (OHI) is the largest by market capitalisation: Omega Healthcare Investors (OHI) $14.36B, Janus Living (JAN) $7.33B.

Which company is more profitable?

Omega Healthcare Investors (OHI) has the highest net margin (Omega Healthcare Investors (OHI) 58.1%, Janus Living (JAN) -0.3%).

Which stock is riskier?

By one-year price volatility, Omega Healthcare Investors (OHI) has been the steadiest (Omega Healthcare Investors (OHI) 21.4%, Janus Living (JAN) 28.9%). Volatility measures how widely the price swings, not the risk of the business.

Do OHI and JAN move together?

Their daily returns over the past year have a correlation of 0.53, a moderate positive relationship. Holding both diversifies more than two closely linked stocks would.

Which is the better stock, OHI and JAN?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Omega Healthcare Investors (OHI) leads on 5. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.